IS there one pandemic, or two? That was a question being asked a year ago, when wealthy countries accounting for only 15% of the global population had 80% of the Covid deaths. Could it be that the rich world was more vulnerable, somehow, because its populations were older, or more individualistic, or had forgotten to be scared of infectious disease…?
This article first appeared in The Guardian on 27 April 2021. To continue reading, click here.
A year ago, when the World Health Organization published a report showing that China had shut down a highly contagious virus in a city of 11 million people, epidemiologist Michael Baker assumed that the international body would advise the rest of the world to follow China’s example. When to his amazement it didn’t, he decided that New Zealand (population 5 million) should go its own way, and started lobbying the government to pursue an elimination strategy…
This article first appeared in The Guardian on 3 March 2021. To continue reading, click here.
AS Africa emerges from its second wave of Covid-19, one thing is clear: having officially clocked up more than 3.8m cases and more than 100,000 deaths, it hasn’t been spared. But the death toll is still lower than experts predicted when the first cases were reported in Egypt just over a year ago. The relative youth of African populations compared with those in the global north – while a major contributing factor – may not entirely explain the discrepancy. So what is really going on in Africa, and what does that continent’s experience of Covid-19 teach us about the disease and ourselves…?
This article first appeared in The Observer on 28 February 2021. To continue reading, click here.
ADAR Poonawalla, 40, is the chief executive of the Serum Institute of India (SII), the Pune-based, family-owned vaccine manufacturer that is producing more Covid-19 vaccines by dose than any other in the world. For now it’s the Oxford/AstraZeneca vaccine rolling off its production lines, but SII has signed contracts with three other developers – Novavax, Codagenix and SpyBiotech – all of which have candidates in the works…
This article first appeared in The Guardian on 14 February 2021. To continue reading, click here.
THE dilemmas are achingly familiar by now. Should we lock down or stay open? If we lock down, when and in what order should the different sectors of the economy open up? What about schools? Places of worship? Cultural and sporting venues…?
This article first appeared in The Observer on 14 February 2021. To continue reading, click here.